Satoshi Hori

Director of Infection Control in 6 group hospitals
Professor of Infection Control Science in the Juntendo University

2004-2008    Selected for The 21st Century Center Of Excellence Program of ministry of educations, culture, sports, science and technology in Japan
2004          Judge Encouraging Prize Winner of Infection Control Team of The Year in England
2011          Awarded for Prize of Hospital Infection Society of England Roll of Honor of Lowbury Lecture
2011          The Best Scientific Paper Award of Japan Society of Infection Prevention and Control


  • Provide educational lecturers at Annual Conference of Japanese Society for Infection Prevention and Control  (Current)
  • Provide a lecture at Annual conference of Asia-Pacific Economic Cooperation as a Japanese representative (Current)
  • Provide lectures at International Consortium for Prevention & Infection Control (2013, 2015)

Japanese Society for Infection Prevention and Control   (Council Member)
Japanese Association for Infectious Disease
Japan Society for Bacteriology
Japan Society for Clinical Microbiology
Japanese Society of Public Health
Japanese Society of Internal Medicine
Japanese Respiratory Society

2009   Guidelines of controlling influenza A H1N1 in hospitals
2011   Guidance of controlling multi-drug resistant Gram negative organisms in healthcare facilities
2012   Practical manual of infection control

Scientific Paper (Including Co-author)

  • Molecular Epidemiology of Community-Associated and hospital-associate Methicillin-resistant Staphylococcus aureus in a Japanese University Hospital
  • Examination of the Sanitization Condition of the Nozzles of Warm-Water Toilet Seats
  • SP21-3 Novel technology against air-borne transmissions in hospital settings
  • An effective active surveillance method for controlling nosocomial MRSA transmission in a Japanese hospital
  • Investigation of nasal meticillin-resistant Staphylococcus aureus carriage in a haemodialysis clinic in Japan
  • MRSA Carriage among Hemodialysis Patients in a Japanese Clinic -Prevalence, Molecular Typing and Risk Factors- Clinical and social problems in controlling multidrug-resistant organisms
  • Heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: A retrospective study
  • Association between antimicrobial consumption and clinical isolates of methicillin-resistant Staphylococcus aureus: A 14-year  study
  • Assessment of Constructive Factors which May Contribute to Improve Hand Washing Compliance by Healthcare Workers in Ordinal Wards
  • Prospective study of antibiotic protocols for managing surgical site infections in children
  • Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections